By affecting SMAD7, vascular endothelial growth factor, renin pathways, and subclinical inflammation, microRNA-21 is involved in the development and progression of hypertension and HMOD, including left ventricular hypertrophy and arterial damage measured by the cIMT and PWV [45]. Here, VEGFA is linked to left ventricular hypertrophy.